Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.10.30.20215301; this version posted November 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study Robert Flisiak1*#, Dorota Zarębska-Michaluk2*, Aleksandra Berkan-Kawińska3, Magdalena Tudrujek-Zdunek4, Magdalena Rogalska1, Anna Piekarska3, Dorota Kozielewicz5, Krzysztof Kłos6, Marta Rorat7,8, Beata Bolewska9, Anna Szymanek-Pasternak10, Włodzimierz Mazur11, Beata Lorenc12, Regina Podlasin13, Katarzyna Sikorska14, Barbara OczkoGrzesik15, Cezary Iwaszkiewicz16, Bartosz Szetela17, Paweł Pabjan2, Małgorzata Pawłowska5, Krzysztof Tomasiewicz4, Joanna Polańska18, Jerzy Jaroszewicz15. *equal contribution # Corresponding author: Prof. Robert Flisiak, Department of Infectious Diseases and Hepatology, Medical University of Bialystok, ul. Zurawia 14, 15-540, Bialystok, Poland. Tel./fax: +48 857416921. Email: robert.flisiak1@gmail.com 1 Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland 2 Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland 3 Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, Poland 4 Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland 5 Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Poland 6 Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland 7 Department of Forensic Medicine, Wrocław Medical University, Wrocław, Poland 8 First Infectious Diseases Ward, Gromkowski Regional Specialist Hospital in Wrocław, Wrocław, Poland. 9 Department of Infectious Diseases, University of Medical Sciences, Poznań, Poland 10 Department of Infectious Diseases and Hepatology, Wrocław Medical University, Wrocław, Poland 11 Clinical Department of Infectious Diseases in Chorzów, Medical University of Silesia, Katowice, Poland 12 Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdańsk, Gdańsk, Poland 13 Hospital of Infectious Diseases in Warsaw, Warsaw, Poland 14 Department of Tropical Medicine and Epidemiology, Medical University of Gdańsk, NOTE: ThisPoland preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. Gdańsk medRxiv preprint doi: https://doi.org/10.1101/2020.10.30.20215301; this version posted November 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 15 Department of Infectious Diseases in Bytom, Medical University of Silesia, Katowice, Poland 16 Department of Rheumatology and Osteoporosis, Jozef Strus Hospital in Poznań, Poland 17 Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Wrocław Medical University, Wrocław, Poland 18 Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland medRxiv preprint doi:..